The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Alx Oncology Holdings Inc’s stock clocked out at $0.49, up 2.08% from its previous closing price of $0.48. In other words, the price has increased by $2.08 from its previous closing price. On the day, 0.81 million shares were traded. ALXO stock price reached its highest trading level at $0.5265 during the session, while it also had its lowest trading level at $0.4656.
Ratios:
To gain a deeper understanding of ALXO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.26 and its Current Ratio is at 7.26. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 06, 2025, Upgraded its rating to Buy and sets its target price to $3 from $2 previously.
On December 19, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $12 to $2.
Stifel Downgraded its Buy to Hold on March 08, 2024, whereas the target price for the stock was revised from $10 to $14.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Pinto Shelly sold 550 shares for $1.15 per share. The transaction valued at 633 led to the insider holds 87,352 shares of the business.
Pons Jaume sold 1,326 shares of ALXO for $1,525 on Feb 19 ’25. The PRESIDENT & CSO now owns 579,388 shares after completing the transaction at $1.15 per share. On Feb 19 ’25, another insider, Lettmann Jason, who serves as the CHIEF EXECUTIVE OFFICER of the company, sold 2,159 shares for $1.15 each. As a result, the insider received 2,483 and left with 170,270 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 26158210 and an Enterprise Value of -84620768.
Stock Price History:
The Beta on a monthly basis for ALXO is 1.26, which has changed by -0.96198606 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -46.08%, while the 200-Day Moving Average is calculated to be -77.25%.
Shares Statistics:
It appears that ALXO traded 1.01M shares on average per day over the past three months and 588430 shares per day over the past ten days. A total of 53.05M shares are outstanding, with a floating share count of 33.99M. Insiders hold about 36.33% of the company’s shares, while institutions hold 56.29% stake in the company. Shares short for ALXO as of 1743379200 were 6295707 with a Short Ratio of 6.24, compared to 1740700800 on 5887074. Therefore, it implies a Short% of Shares Outstanding of 6295707 and a Short% of Float of 20.26.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
